Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Glenmark Pharma Plunges 3%; BSE HEALTHCARE Index Up 0.4%
Fri, 16 Aug 9:26

Glenmark Pharma Plunges 3%; BSE HEALTHCARE Index Up 0.4%Image source: Sefa Ozel/www.istockphoto.com

Glenmark Pharma share price has plunged 3% and is presently trading at Rs 1,448.0.

Meanwhile, the BSE HEALTHCARE index is at 40,955.5 (up 0.4%).

Among the top losers in the BSE HEALTHCARE index today are IPCA Labs (down 1.0%) and ALKEM LABORATORIES (down 0.6%).

GSK Pharma (up 2.5%) and J.B.Chemicals (up 2.4%) are among the top gainers today.

Over the last one year, Glenmark Pharma has moved up from Rs 797.6 to Rs 1,448.0, registering a gain of Rs 650.5 (up 81.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 40,955.5, registering a gain of 47.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 130.4%), Jubilant Pharmova (up 104.3%) and GSK Pharma (up 104.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,740.3 (up 0.8%).

The top gainers among the BSE Sensex today are M&M (up 2.6%) and Tata Motors (up 2.2%). The most traded stocks in the BSE Sensex are Tata Steel and Nestle.

In the meantime, NSE Nifty is at 24,393.4 (up 1.0%). M&M and Tata Motors are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 79,740.3, registering a gain of 14,338.4 points (up 21.9%).

Glenmark Pharma Financial Update...

Glenmark Pharma net profit grew 803.0% YoY to Rs 3,402 million for the quarter ended June 2024, compared to a profit of Rs 377 million a year ago. Net sales rose 6.9% to Rs 32,442 million during the period as against Rs 30,361 million in April-June 2023.

For the year ended March 2023, Glenmark Pharma reported 62.0% decrease in net profit to Rs 3,774 million compared to net profit of Rs 9,936 million during FY22. Revenue of the company grew 5.6% to Rs 129,901 million during FY23.

The current Price to earnings ratio of Glenmark Pharma, based on rolling 12 month earnings, stands at -26.7.


Equitymaster requests your view! Post a comment on "Glenmark Pharma Plunges 3%; BSE HEALTHCARE Index Up 0.4%". Click here!